EDISON, N.J.--(BUSINESS WIRE)--I-many, Inc. (NASDAQ:IMNY), the leading provider of advanced Contract Lifecycle Management (CLM) solutions for managing corporate commitments, today announced that Ferndale Laboratories, a leading dermatological pharmaceuticals company delivering unique therapies that help heal, protect, and beautify the skin, has signed a five-year license agreement to implement I-many CARS and I-many Medicaid. I-many’s integrated approach to Contract Lifecycle Management will enable Ferndale to optimize rebates and chargebacks as their business grows and as regulatory requirements increase.
